Joycos Intl Ltd
✅ Low Risk
FEI: 3011535444 • Seoul • SOUTH KOREA
FEI Number
3011535444
Location
Seoul
Country
SOUTH KOREAAddress
4f Hyobong Bd 13 Nambusunhwan, , Seoul, , South Korea
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
CSTIC LBLG
The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.
COSMETLBLG
It appears that the cosmetic consists of two or more ingredients and the label does not list the common or usual name of each ingredient.
Refusal History
Frequently Asked Questions
What is Joycos Intl Ltd's FDA import refusal history?
Joycos Intl Ltd (FEI: 3011535444) has 1 FDA import refusal record(s) in our database, spanning from 6/29/2016 to 6/29/2016.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Joycos Intl Ltd's FEI number is 3011535444.
What types of violations has Joycos Intl Ltd received?
Joycos Intl Ltd has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Joycos Intl Ltd come from?
All FDA import refusal data for Joycos Intl Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.